ImmunoGen, Inc.

COMMONWEALTH EQUITY SERVICES, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/6/2024

Shares

23,980

Value ($000)

711

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/6/2024	711	0.0%	23,980	12/31/2023
2023 Q3	10/23/2023	411	0.0%	25,877	9/30/2023
2023 Q2	8/10/2023	517	0.0%	27,379	6/30/2023
2023 Q1	5/11/2023	688	0.0%	179,219	3/31/2023
2022 Q4	2/7/2023	838	0.0%	169,094	12/31/2022
2022 Q3	11/14/2022	796	0.0%	166,685	9/30/2022
2022 Q2	7/19/2022	754	0.0%	167,589	6/30/2022
2022 Q1	5/4/2022	143	0.0%	30,055	3/31/2022
2021 Q4	1/31/2022	224	0.0%	30,216	12/31/2021
2021 Q3	10/29/2021	172	0.0%	30,336	9/30/2021
2021 Q2	8/11/2021	154	0.0%	23,506	6/30/2021
2021 Q1	5/4/2021	357	0.0%	44,086	3/31/2021
2020 Q4	2/11/2021	162	0.0%	25,258	12/31/2020
2020 Q3	11/5/2020	92	0.0%	25,724	9/30/2020
2020 Q2	8/12/2020	107	0.0%	23,452	6/30/2020
2020 Q1	5/11/2020	156	0.0%	45,999	3/31/2020
2019 Q4	2/5/2020	191	0.0%	37,596	12/31/2019